Skip to main content

EDITORIAL article

Front. Pediatr., 01 February 2024
Sec. Pediatric Pulmonology
This article is part of the Research Topic Emerging Pneumonia and Acute Lower Respiratory Infections in Children, Volume II View all 6 articles

Editorial: Emerging pneumonia and acute lower respiratory infections in children, volume II

  • 1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  • 2College of Medicine, Chang Gung University, Taoyuan, Taiwan
  • 3Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
  • 4Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Editorial on the Research Topic
Emerging pneumonia and acute lower respiratory infections in children, volume II

After the COVID-19 pandemic, there have been some changes in the incidence and influencing factors of childhood pneumonia. Although almost all children with pneumonia associated with COVID-19 have a favorable outcome, there have been long-term consequences similar to other viral pneumonias. Some studies have also indicated an increase in the incidence of childhood pneumonia post-COVID-19, partly attributed to changes in its etiology (1, 2). Additionally, there has been an increase in more severe cases of community-acquired pneumonia in children, possibly due to the reduced exposure to bacterial and viral pathogens and decreased immune system training as a result of non-pharmaceutical interventions implemented during the COVID-19 period, leading to what is known as “immunological debt” (3). Given the changes in the era and environment and the advancements in science, management strategies for childhood pneumonia also need to be based on new evidence and treatment guidelines. Frontiers in Pediatrics has planned “Emerging Pneumonia and Acute Lower Respiratory Infections in Children, Volume II” to highlight the latest developments in this field. This special issue includes 5 articles.

Artificial intelligence (AI) plays a pivotal role in predicting disease prognosis and guiding medical decision-making. By integrating diverse personal data, AI offers more effective disease prevention and treatment decisions, thereby enhancing patient outcomes with precise medical information. Moreover, AI applications in medical imaging can elevate early diagnosis rates, leading to improved treatment efficiency (4).

The nomogram has gained significant application and clinical significance in the field of oncology (5), whereas its application in pediatric respiratory diseases is relatively new. It is essential for clinical practitioners to fully understand the advantages and limitations of using nomograms in clinical practice to achieve better outcomes. Nomograms utilize statistical models to combine multiple predictive factors, providing an intuitive and quantitative prognosis estimate. By inputting specific patient data into the appropriate nomogram model, clinical practitioners can estimate a patient's prognosis to consider treatment strategies.

A prediction model for the efficacy of continuous positive airway pressure (CPAP) on bronchiolitis

In this article, Shi et al. included 510 children and established a nomogram predictive model consisting of 10 predictor variables, including fever, APTT, white blood cell count, blood potassium concentration, lactate, immunodeficiency, atelectasis, consolidation, congenital airway malformations, and congenital heart disease. This model accurately predicts the likelihood of children with bronchiolitis being able to discontinue CPAP therapy within 48 h. The nomogram predictive model can help clinical staff intuitively understand the multifaceted impact of various factors on the effectiveness of CPAP for bronchiolitis and can be applied in hospitals of different levels.

A nomogram for predicting severe adenovirus pneumonia in children

In this study, Zhang et al. enrolled 132 patients with non-severe adenovirus pneumonia, of whom 30 progressed to severe adenovirus pneumonia and 102 developed mild adenovirus pneumonia. The researchers utilized respiratory rate, neutrophil percentage, lymphocyte percentage, and LDH as key clinical indicators to construct a nomogram predictive model for predicting the likelihood of severe adenovirus pneumonia. This predictive model aids in early identification of children at risk of progressing to severe adenovirus pneumonia.

Although the aforementioned two predictive models demonstrated excellent discriminative ability as well as high sensitivity and specificity in the retrospective cohort, there are limitations to the nomogram model. First, the construction of the nomogram is based on historical long-term clinical data, and it cannot promptly update the prognosis prediction when patients undergo new treatment regimens or experience new clinical conditions. Second, the nomogram is heavily reliant on accurate clinical data as input, thus it may not accurately predict in situations of insufficient data. Third, the nomogram may consist of multiple variables, leading to complex relationships such as nonlinearity, interaction effects, and multicollinearity. This makes it difficult to intuitively understand the overall structure of the model and the influencing factors, and it is challenging to interpret the prediction process using simple rules. Fourth, it is not appropriate to directly compare the AUC of ROC curves generated using different databases. While the AUC is a discerning indicator of model accuracy, differences in AUC (Area Under the Curve) between ROC curves do not necessarily indicate the clinical significance of each curve. Even with similar variables, AUC may be influenced by different patient groups.

In order to reduce antibiotic overuse and avoid misdiagnosis in the context of pathogen infections in childhood pneumonia, it is recommended to refer to treatment guidelines developed by experts based on local specific patterns of pathogen drug resistance and prevalence (6). Additionally, timely use of bronchoscopy and modern diagnostic techniques can be employed to identify the specific pathogens causing the infection and select appropriate treatment strategies, thus avoiding indiscriminate antibiotic use (79). Using the positive association between elevated CRP levels and bacterial pneumonia to appropriately determine the timing for antibiotic utilization. Appropriately utilizing the positive correlation between elevated CRP levels and bacterial pneumonia to determine the timing of antibiotic use can help reduce antibiotic overuse while avoiding ineffective treatment due to inadequate antibiotic use. Certainly, adequate nutrition and comprehensive immunization are also important strategies for reducing the occurrence of childhood pneumonia.

Metagenomic next-generation sequencing in a diagnosis of Pneumocystis pneumonia in an X-linked immunodeficient child: a case report

Lu et al. reported a 6-month-old male infant with X-linked immunodeficiency presenting with pneumonia and sepsis. When conventional diagnostic methods failed to identify the pathogen, blood metagenomic next-generation sequencing helped identify 133 specific nucleic acid sequences of Pneumocystis pneumonia, indicating the presence of this pathogen infection. This case report highlights the value of metagenomic next-generation sequencing in diagnosing PCP.

The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia

In this article, Nguyen et al. conducted a comprehensive review of the disease burden, pathogens, case management, and current available prevention strategies for community-acquired pneumonia in children, with a particular emphasis on the rational use of antibiotics in children pneumonia to stimulate critical assessment of appropriate antibiotic use.

Recurrent respiratory tract infections in children might be associated with vitamin A status: a case-control study

Zhang et al. investigated the association between vitamin A status in children and recurrent respiratory tract infections (RRTIs), as well as the relationship between dietary vitamin A intake and RRTIs. The results revealed that low serum vitamin A levels were associated with a higher incidence of RRTIs in children, and a low intake of vitamin A-rich foods was also associated with the development of RRTIs. It is unknown whether vitamin A deficiency is directly related to the occurrence of RRTIs, and whether vitamin A supplementation can reduce the occurrence of recurrent respiratory tract infections. Future research should further validate across different ethnic groups and elucidate the molecular mechanisms of vitamin A deficiency leading to RRTIs.

Author contributions

H-RY: Writing – original draft, Writing – review & editing. J-HH: Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Meng Q, Li W, Jiang H, Yan H, Wang H, Ye B, et al. Comparison of the distribution and changes in the antibiotic resistance of clinical bacterial isolates from the lower respiratory tract of children in Shenzhen before the epidemic, during the epidemic, and during the period of normalized prevention and control of COVID-19. Infect Dis Ther. (2023) 12(2):563–75. doi: 10.1007/s40121-022-00751-4

PubMed Abstract | Crossref Full Text | Google Scholar

2. Song SH, Lee H, Lee HJ, Song ES, Ahn JG, Park SE, et al. Twenty-five year trend change in the etiology of pediatric invasive bacterial infections in Korea, 1996–2020. J Korean Med Sci. (2023) 38(16):e127. doi: 10.3346/jkms.2023.38.e127

PubMed Abstract | Crossref Full Text | Google Scholar

3. de Ceano-Vivas M, Molina Gutierrez MA, Mellado-Sola I, Garcia Sanchez P, Grandioso D, Calvo C, et al. Streptococcus pyogenes infections in Spanish children before and after the COVID pandemic. Coming back to the previous incidence. Enferm Infecc Microbiol Clin. (2023) 23:187–9. doi: 10.1016/j.eimce.2023.04.021

Crossref Full Text | Google Scholar

4. Chen KC, Yu HR, Chen WS, Lin WC, Lee YC, Chen HH, et al. Diagnosis of common pulmonary diseases in children by x-ray images and deep learning. Sci Rep. (2020) 10(1):17374. doi: 10.1038/s41598-020-73831-5

PubMed Abstract | Crossref Full Text | Google Scholar

5. Bandini M, Fossati N, Briganti A. Nomograms in urologic oncology, advantages and disadvantages. Curr Opin Urol. (2019) 29(1):42–51. doi: 10.1097/MOU.0000000000000541

PubMed Abstract | Crossref Full Text | Google Scholar

6. Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. (2021) 54(4):557–65. doi: 10.1016/j.jmii.2020.10.002

PubMed Abstract | Crossref Full Text | Google Scholar

7. Tsai CM, Wong KS, Lee WJ, Hsieh KS, Hung PL, Niu CK, et al. Diagnostic value of bronchoalveolar lavage in children with nonresponding community-acquired pneumonia. Pediatr Neonatol. (2017) 58(5):430–6. doi: 10.1016/j.pedneo.2016.09.004

PubMed Abstract | Crossref Full Text | Google Scholar

8. Lee WJ, Huang EY, Tsai CM, Kuo KC, Huang YC, Hsieh KS, et al. Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of mycoplasma pneumoniae-related pneumonia in school-age children and adolescents. Clin Vaccine Immunol. (2017) 24(1):e00471-16. doi: 10.1128/CVI.00471-16

PubMed Abstract | Crossref Full Text | Google Scholar

9. Buchan BW, Windham S, Balada-Llasat JM, Leber A, Harrington A, Relich R, et al. Practical comparison of the BioFire FilmArray pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol. (2020) 58(7):e00135-20. doi: 10.1128/JCM.00135-20

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: children, pneumonia, respiratory tract, infection, pediatric

Citation: Yu H-R and Hsu J-H (2024) Editorial: Emerging pneumonia and acute lower respiratory infections in children, volume II. Front. Pediatr. 12:1372533. doi: 10.3389/fped.2024.1372533

Received: 18 January 2024; Accepted: 23 January 2024;
Published: 1 February 2024.

Edited and Reviewed by: Anne B. Chang, Charles Darwin University, Australia

© 2024 Yu and Hsu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jong-Hau Hsu jhh936@yahoo.com.tw

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.